Bio-Rad Laboratories, Inc.(NYSE : BIO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||-1.77%||507.47||1.0%||$627.63m|
|ISRG||Intuitive Surgical, Inc.||-0.86%||187.44||0.8%||$338.31m|
|BSX||Boston Scientific Corp.||-1.47%||38.76||1.0%||$258.59m|
|BDX||Becton, Dickinson & Co.||-1.46%||222.83||1.0%||$255.81m|
|EW||Edwards Lifesciences Corp.||-1.34%||82.71||0.4%||$237.54m|
|ALGN||Align Technology, Inc.||-1.85%||207.11||6.4%||$191.01m|
|A||Agilent Technologies, Inc.||-0.84%||121.71||1.7%||$182.61m|
|BAX||Baxter International, Inc.||-2.50%||53.92||1.8%||$166.39m|
|STE||STERIS Plc (Ireland)||-0.27%||166.66||3.1%||$137.19m|
|SWAV||Shockwave Medical, Inc.||0.81%||278.07||0.0%||$136.12m|
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.